SIRT1 Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the Oxidative Stress and p38MAPK Pathways
Author(s) -
Yang Ruan,
Chunlin Dong,
J. Patel,
Chao Duan,
Xinyue Wang,
Xi Wu,
Yuan Cao,
Lianmei Pu,
Dan Lu,
Tao Shen,
Jian Li
Publication year - 2015
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000373937
Subject(s) - doxorubicin , sirtuin 1 , sirtuin , resveratrol , apoptosis , oxidative stress , biology , reactive oxygen species , tunel assay , microbiology and biotechnology , cardiotoxicity , myocyte , dna laddering , programmed cell death , pharmacology , cancer research , nad+ kinase , endocrinology , downregulation and upregulation , medicine , biochemistry , enzyme , toxicity , chemotherapy , dna fragmentation , gene
SIRT1, which belongs to the Sirtuin family of NAD-dependent enzymes, plays diverse roles in aging, metabolism, and disease biology. It could regulate cell survival and has been shown to be a protective factor in heart function. Hence, we verified the mechanism by which SIRT1 regulates doxorubicin induced cardiomyocyte injury in vivo and in vitro.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom